Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study

Tarih

Yazarlar

Olmez, Omer Fatih

Kaplan, Muhammed Ali

Oksuzoglu, Berna

Karadurmus, Nuri

Sendur, Mehmet Ali Nahit

DOI No

10.1080/0284186X.2023.2202330

Diğer Tanımlayıcı No

WOS:000971681800001

Yayınevi

Medical Journal Sweden AB

Anahtar kelimeler

HER2 protein positive, breast cancer, neoadjuvant treatment, pertuzumab, trastuzumab, event\\-free survival, relapse, real\\-word evidence

URI

https://openaccess.acibadem.edu.tr/handle/11443/6477

Koleksiyonlar

Tam öğe sayfası